
Major provider of medical-surgical products and integrated solutions

Medline is a major provider of medical-surgical products and integrated healthcare supply chain solutions, offering over 335,000 products for all types of healthcare facilities and supported by extensive manufacturing and logistics infrastructure. The Medline IPO, representing a highly experienced and large U.S. medtech player, falls into the category of blockbuster offerings and is the largest since 2011. It is particularly attractive to a broad range of investors due to its relatively low risk profile compared to most healthcare IPOs (especially biotech companies, which have been frequent issuers in recent years), while still offering a reasonably balanced valuation range. The company generates over $25 billion in annual revenue and employs approximately 43,000 people (comparable to Boston Scientific or about half the size of Medtronic’s workforce).
Risk Warning: Investing in financial instruments involves risks. The value of investments may increase or decrease. Past results do not guarantee future returns. We recommend consulting a financial advisor before making investment decisions.
Open the product card in Telegram for full information and application
Open in TelegramAll available investment solutions, detailed product cards, and the ability to access them — in our Telegram Mini App
Open Telegram Mini App